The Peptide NewsroomPeptide research, industry and supply-chain headlines

ProGlow Labs Launches Eight Peptide Formulas, But the Press Release Cites No Trials

Topic card: skin-beauty hair

ProGlow Labs, a Las Vegas skincare and hair care brand, has announced the launch of eight new products built around named cosmetic peptides. The collection covers three facial serums, a moisturizer, an eye treatment, a lip treatment and two hair care formulas.

Peptides are short chains of amino acids used in skincare formulations for cosmetic purposes. The company says it built the collection around specifically identified peptides including GHK-Cu, the copper peptide widely used in topical products, SNAP-8 and KPV, picking a peptide per concern rather than putting the same blend in every bottle.

What is actually in the bottles

The most specific product description in the announcement is Recovery, a calming serum aimed at sensitive and reactive-looking skin. It pairs KPV and copper peptide with 5% niacinamide and 3% ectoin, and the company says it is designed to help improve the appearance of redness and support a healthier-looking skin barrier.

That is appearance language throughout, which is what cosmetic regulation requires and also what the brand has stuck to. The formulas are described as cruelty-free and made without parabens, sulfates, mineral oil, drying alcohols, formaldehyde releasers or added dyes.

The timeline claim is the interesting part

"Peptides are not an overnight fix, and most people should give a routine 4 to 8 weeks of consistent use before judging the results," the company said in its statement. Setting an expectation that pushes the payoff two months out is unusual for a launch release, and it is a more honest framing than most of this category manages.

It also happens to be unfalsifiable from the consumer's side, which is worth noticing. Four to eight weeks is long enough that almost any change gets credited to the product.

Where the evidence stops

There is no study here. No trial, no outcome figure, no published data on any of the eight formulas, and no researcher or dermatologist quoted anywhere in the announcement. The company says it works with a leading skincare laboratory and that its formulas are developed by peptide experts, neither of which is named.

The brand does publish an index of 14 peptides and their intended cosmetic uses, including Matrixyl 3000 and Eyeseryl. Ingredient transparency is genuinely useful and still is not evidence.

Bottom line

A launch release is a launch release, and this one is more specific about its actives than most. What it does not contain is a single result anyone measured.

Source: RSS.app — Peptides bundle. Read the original.

Filed under: skin-beauty, hair

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

Renue By Science Says 95% Reported Smoother Skin, But Its Study Had No Control Group

Renue By Science reports that 95% of participants in a four-week study said their skin felt smoother after using its liposomal NAD+ and Methylene Blue body cream. The company also discloses that the study was single-arm, virtual, and based entirely on self-reported perceptions from 38 women.

NSW Emergency Visits Linked to Unapproved Peptides Jump From 5 a Month to 220

NSW Health data shows monthly emergency department visits linked to unapproved peptide use rose from 5 in July 2025 to almost 220 last month, with 1,180 presentations recorded over 15 months. Authorities named BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 among compounds that may appear in unapproved products.

Sponsored Explainer Pitches a Three-Peptide Growth Hormone Blend, but Cites No Trial Data

A sponsored article on Elizabethton.com makes the case for studying Fragment 176-191, Modified GRF 1-29, and Ipamorelin together as a multi-pathway research platform. Every mechanistic claim in it is hedged, and no trial, dose, species or outcome figure appears anywhere.